Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Oxford Health Plan (OXHP) -- Ignore unavailable to you. Want to Upgrade?

To: Vijay Sonty who wrote (341)	12/5/1997 1:15:00 PM
From: Christopher White	Read Replies (2) \| Respond to of 2068

Vijay, Your point is valid, though I don't agree with your conclusion. OXHP has highly paid actuaries who should be able to determine a proper premium for these older Americans based on the morbitity of the group. In life insurance, companies love to sell those term policies for exactly that reason, namely when a person is young, the mortality is low so the policy is cheap (people think term is a bargain), however, when the person gets older the policy gets so expensive that it is no longer economical for that person to pay the premium...this is why over 99% of term policies never pay out the face amount...at this point the person may be uninsurable and a limited pay VUL for example is too expensive, so that person's family suffers since he has no life insurance to preserve the value of the estate upon his death. It seem to me that if OXHP can't make money off the gov't cash cow Medicare, their case managers aren't doing their job. OXHP doesn't have to accept assignment of a claim...if the care is more expensive than Medicare's approved amount, than the excess charge will paid by the patient. Christopher